ArticleFrontiers in endocrinology2026
Early postpartum dysglycemia after gestational diabetes: β-cell dysfunction and risk stratification in a multiethnic cohort.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Postpartum oral glucose tolerance test (OGTT) screening is recommended after gestational diabetes (GDM), but attendance is often incomplete and testing may not capture metabolic heterogeneity. Western-derived risk models may be less applicable to Asians, in whom Methods: We retrospectively studied 575 women with GDM managed at a tertiary center in Singapore between 01/10/2023 to 30/04/2025. Early postpartum Results: Postpartum OGTT completion rate was 71.1% (409/575). Among women tested, 34.2% (140/409) had early postpartum dysglycemia. Dysglycemia occurred in a relatively lean phenotype and was associated with lower homeostatic model assessment of β-cell function (HOMA-β). Independent predictors were family history of diabetes, prior GDM, elevated pregnancy 2-hours OGTT glucose, Chinese ethnicity, and higher HbA1c while Conclusions: Early postpartum dysglycemia after GDM was common and appeared consistent with a relatively lean, β-cell-predominant phenotype. Pragmatic risk stratification may complement tiered postpartum surveillance and prevention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.